Iridoids and Amino Acid Derivatives from the Paraguayan Crude Drug Adenocalymma marginatum (ysypo hu)

Schmeda-Hirschmann G.; Burgos-Edwards A.; Jiménez-Aspee F.; Mieres-Castro D.; Theoduloz C.; Pormetter L.; Fogel R.; Céspedes C.; Soria N.; Valdez S.

Abstract

The crude drug ysypo hu (Adenocalymma marginatum DC., Bignoniaceae) is used traditionally by the Guarani of Eastern Paraguayan as a male sexual enhancer. The aim of the present study was to identify the main constituents of the crude drug and to evaluate the in vitro inhibitory activity towards the enzyme phosphodiesterase-5 (PDE-5). The main compounds were isolated by counter-current chromatography (CCC). The metabolites were identified by spectroscopic and spectrometric means. The chemical profiling of the extracts was assessed by high-performance liquid chromatography coupled to mass spectrometry (HPLC-MS/MS). The crude extract and main isolated compounds were tested for their PDE-5 inhibitory activity using commercial kits. The iridoid theviridoside and 4-hydroxy-1-methylproline were isolated as the main constituent of the crude drug. Four chlortheviridoside hexoside derivatives were detected for the first time as natural products. Chemical profiling by HPLC-MS/MS led to the tentative identification of nine iridoids, six phenolics, and five amino acids. The crude extracts and main compounds were inactive towards PDE-5 at concentrations up to 500 mu g/mL. Iridoids and amino acid derivatives were the main compounds occurring in the Paraguayan crude drug. The potential of ysypo hu as a male sexual enhancer cannot be discarded, since other mechanisms may be involved.

Más información

Título según WOS: Iridoids and Amino Acid Derivatives from the Paraguayan Crude Drug Adenocalymma marginatum (ysypo hu)
Título según SCOPUS: Iridoids and amino acid derivatives from the paraguayan crude Drug Adenocalymma marginatum (ysypó hû)
Título de la Revista: MOLECULES
Volumen: 25
Número: 1
Editorial: MDPI
Fecha de publicación: 2020
Idioma: English
DOI:

10.3390/molecules25010180

Notas: ISI, SCOPUS